We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
10 Year Est. Return
AUM
$3.6B
AUM Growth
-$6.61M
Cap. Flow
-$25.8M
Cap. Flow %
-0.72%
Top 10 Hldgs %
39.47%
Holding
4,012
New
939
Increased
926
Reduced
932
Closed
1,189

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 6.08%
2 Healthcare 5.42%
3 Technology 5.41%
4 Financials 5.37%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INOV
2276
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$154K ﹤0.01%
+11,709
New +$152K
SAUC
2277
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$154K ﹤0.01%
59,163
+21,181
+56% +$60.5K
RELY
2278
DELISTED
Real Industry, Inc.
RELY
$154K ﹤0.01%
53,160
+22,646
+74% +$61.8K
BDSI
2279
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$154K ﹤0.01%
54,908
-55,820
-50% -$118K
DHT icon
2280
DHT Holdings
DHT
$2.99B
$153K ﹤0.01%
36,814
-10,728
-23% -$46.7K
CVM.WS
2281
DELISTED
Cel-Sci Corp Series S
CVM.WS
$153K ﹤0.01%
+2,120,027
New +$70.6K
IMDZ
2282
DELISTED
Immune Design Corp.
IMDZ
$153K ﹤0.01%
+15,706
New +$110K
NBR icon
2283
Nabors Industries
NBR
$1.12B
$152K ﹤0.01%
373
-1,806
-83% -$909K
NNVC icon
2284
NanoViricides
NNVC
$37M
$152K ﹤0.01%
+5,631
New +$139K
SEF icon
2285
ProShares Short Financials
SEF
$13M
$152K ﹤0.01%
+1,465
New +$157K
PGNX
2286
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$152K ﹤0.01%
22,433
-56,936
-72% -$420K
EC icon
2287
Ecopetrol
EC
$32.5B
$151K ﹤0.01%
16,579
+2,743
+20% +$25.7K
TCRT icon
2288
Alaunos Therapeutics
TCRT
$4.64M
$151K ﹤0.01%
162
-362
-69% -$355K
WPRT
2289
Westport Fuel Systems
WPRT
$32.9M
$150K ﹤0.01%
6,375
-6,338
-50% -$98.8K
EVFM
2290
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$150K ﹤0.01%
+3,091
New +$542K
SEA
2291
DELISTED
Invesco Shipping ETF
SEA
$150K ﹤0.01%
+12,669
New +$149K
BNO icon
2292
United States Brent Oil Fund
BNO
$724M
$149K ﹤0.01%
+11,439
New +$156K
CAPR icon
2293
Capricor Therapeutics
CAPR
$380M
$149K ﹤0.01%
17,930
+15,261
+572% +$279K
PML
2294
PIMCO Municipal Income Fund II
PML
$487M
$149K ﹤0.01%
+11,316
New +$147K
VXRT
2295
DELISTED
Vaxart
VXRT
$149K ﹤0.01%
+20,267
New +$121K
NVCN
2296
DELISTED
Neovasc Inc.
NVCN
$149K ﹤0.01%
+4
New +$154K
PER
2297
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$149K ﹤0.01%
51,282
+24,690
+93% +$74.9K
PXJ icon
2298
Invesco Oil & Gas Services ETF
PXJ
$63.4M
$148K ﹤0.01%
+3,160
New +$163K
XS
2299
DELISTED
Elkhorn S&P MidCap Consumer Staples Portfolio
XS
$148K ﹤0.01%
+10,077
New +$152K
ALDW
2300
DELISTED
Alon USA Partners LP
ALDW
$148K ﹤0.01%
+14,127
New +$144K

Similar funds

Virtu KCG Holdings's Q2 2017 Portfolio in Review

As of Q2 2017, Virtu KCG Holdings held 4,012 positions worth $3.6B, down 0.18% from $3.61B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Virtu KCG Holdings's Q2 2017 filing shows 939 new, 926 increased, 932 reduced and 1,189 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 1,021,442 shares worth $28.2M. The largest sale was JPMorgan Chase, an estimated $13.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 6.1% of assets, down from 6.2% a quarter earlier, followed by Healthcare and Technology.

  • Virtu KCG Holdings's largest Q2 2017 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 1,021,442 shares worth $28.2M.
  • Virtu KCG Holdings added most to Alphabet (Google) Class C in Q2 2017, an estimated $13.8M increase.
  • Virtu KCG Holdings's biggest Q2 2017 reduction was JPMorgan Chase, cutting an estimated $13.2M.
  • Virtu KCG Holdings fully exited Viatris in Q2 2017, selling an estimated $7.94M.
  • Virtu KCG Holdings's ten largest holdings make up 39% of its $3.6B portfolio in Q2 2017.
  • Virtu KCG Holdings opened 939 new positions and closed 1,189 in Q2 2017.
  • Virtu KCG Holdings's portfolio value fell 0.18% quarter-over-quarter to $3.6B.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.